Literature DB >> 19182713

[Combined apical emphysema and basal fibrosis syndrome (emphysema/fibrosis syndrome): CT imaging features and pulmonary function tests].

P Y Brillet1, V Cottin, P Letoumelin, F Landino, M W Brauner, D Valeyre, J F Cordier, H Nunes.   

Abstract

PURPOSE: To describe the high resolution CT (HRCT) imaging and functional features of the emphysema/fibrosis syndrome. PATIENTS AND METHODS: A total of 61 patients were included based on HRCT. We have quantified the extent of fibrosis and emphysema lesions and a combined score was calculated. The scores were correlated to pulmonary function test parameters and specific HRCT features were described.
RESULTS: The emphysema and fibrosis scores correlated with functional parameters of obstruction and restriction respectively. The combined score correlated with the reduction in DLCO and degree of pulmonary hypertension. Three HRCT patterns were identified: progressive transition (n=23, 38%) with diffuse emphysema (centrilobular and/or bullous) and zone of transition between bullae and honeycombing; paraseptal emphysema (n=13, 21%) with predominant subpleural bullae of enlarging size at the bases; separate processes (n=14, 23%) with independent areas of fibrosis and emphysema. Eleven patients (18%) could not be classified. The HRCT imaging features changed based on TLC (p=0.04) and FEV1/FVC (p=0.01).
CONCLUSION: The emphysema/fibrosis syndrome may be associated with different patterns on HRCT corresponding to specific profiles on pulmonary function tests.

Entities:  

Mesh:

Year:  2009        PMID: 19182713     DOI: 10.1016/s0221-0363(09)70077-0

Source DB:  PubMed          Journal:  J Radiol        ISSN: 0221-0363


  13 in total

Review 1.  Combined pulmonary fibrosis and emphysema (CPFE): an entity different from emphysema or pulmonary fibrosis alone.

Authors:  Huijin Lin; Shanping Jiang
Journal:  J Thorac Dis       Date:  2015-04       Impact factor: 2.895

Review 2.  Combined pulmonary fibrosis and emphysema (CPFE): what radiologist should know.

Authors:  Federica Ciccarese; Domenico Attinà; Maurizio Zompatori
Journal:  Radiol Med       Date:  2016-02-19       Impact factor: 3.469

3.  Pulmonary fibrosis and emphysema: Is the emphysema type associated with the pattern of fibrosis?

Authors:  Anastasia Oikonomou; Paraskevi Mintzopoulou; Argyris Tzouvelekis; Petros Zezos; George Zacharis; Anastasios Koutsopoulos; Demosthenes Bouros; Panos Prassopoulos
Journal:  World J Radiol       Date:  2015-09-28

Review 4.  Normal expiratory flow rate and lung volumes in patients with combined emphysema and interstitial lung disease: a case series and literature review.

Authors:  Karen L Heathcote; Donald W Cockcroft; Derek A Fladeland; Mark E Fenton
Journal:  Can Respir J       Date:  2011 Sep-Oct       Impact factor: 2.409

5.  Combined Pulmonary Fibrosis and Emphysema Syndrome: A New Phenotype within the Spectrum of Smoking-Related Interstitial Lung Disease.

Authors:  Karina Portillo; Josep Morera
Journal:  Pulm Med       Date:  2012-02-09

6.  Imaging diagnosis of interstitial pneumonia with emphysema (combined pulmonary fibrosis and emphysema).

Authors:  Fumikazu Sakai; Junya Tominaga; Akiko Kaga; Yutaka Usui; Minoru Kanazawa; Takashi Ogura; Noriyo Yanagawa; Tamiko Takemura
Journal:  Pulm Med       Date:  2012-02-09

Review 7.  Combined pulmonary fibrosis and emphysema: an increasingly recognized condition.

Authors:  Olívia Meira Dias; Bruno Guedes Baldi; André Nathan Costa; Carlos Roberto Ribeiro Carvalho
Journal:  J Bras Pneumol       Date:  2014 May-Jun       Impact factor: 2.624

Review 8.  Severe pulmonary hypertension due to combined pulmonary fibrosis and emphysema: another cause of death among smokers.

Authors:  André Carramenha de Góes Hirano; Eduardo Pelegrineti Targueta; Fernando Peixoto Ferraz de Campos; João Augusto Dos Santos Martines; Dafne Andrade; Silvana Maria Lovisolo; Aloisio Felipe-Silva
Journal:  Autops Case Rep       Date:  2017-06-30

9.  A New Variant of Combined Pulmonary Fibrosis and Emphysema From Second-Hand Smoke: A Case Report and Review of Literature.

Authors:  Rafay Khan; Sunil Tulpule; Nneka Iroka; Shuvendu Sen; Teena Mathew; Mohammad Islam; Abdalla Yousif; Stacey Longo
Journal:  J Clin Med Res       Date:  2015-08-23

10.  The Gly82Ser mutation in AGER contributes to pathogenesis of pulmonary fibrosis in combined pulmonary fibrosis and emphysema (CPFE) in Japanese patients.

Authors:  Takumi Kinjo; Yoshiaki Kitaguchi; Yunden Droma; Masanori Yasuo; Yosuke Wada; Fumika Ueno; Masao Ota; Masayuki Hanaoka
Journal:  Sci Rep       Date:  2020-07-30       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.